Clinical trials
Phase 3 COVID-19 trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2020 | 30 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 19 |
| Completed | 13 |
| Unknown status | 7 |
| Recruiting | 5 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 12 |
| Centre Hospitalier St Anne | 3 |
| Gilead Sciences | 3 |
| AstraZeneca | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| University Hospital, Strasbourg, France | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Apogenix GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 47 |
| Pneumonia | 9 |
| Respiratory Distress Syndrome | 9 |
| Coronavirus Infections | 7 |
| Respiratory Tract Infections | 4 |
| Community-Acquired Pneumonia | 3 |
| Cytokine Release Syndrome | 3 |
| Infections | 3 |
| Lung Diseases | 3 |
| Pneumonia, Viral | 3 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.